Why Your Pre-Bed HGH Injection Is Built For The Wrong Body

Your liver does not care how much growth hormone is in your blood. It cares whether insulin is there to co-sign the conversion.

That single distinction explains why two people can run the same dose of HGH at different times of day and get completely different IGF-1 outputs, and it explains why the most common timing protocol in performance circles is built on a study that never applied to them in the first place.

Start with the full picture. Growth hormone is produced in the pituitary, which is a small gland at the base of your brain, and it travels to the liver where it triggers the production of something called IGF-1, which is insulin-like growth factor 1 and is the actual anabolic signal responsible for most of what people attribute to growth hormone itself. The growth hormone is the messenger. The IGF-1 is the work getting done. Everything about timing optimization is really about maximizing that conversion step at the liver, because if the conversion does not happen efficiently, the hormone circulates and clears without producing much of the effect you were after.

Now here is what the liver needs to do that conversion well. It needs insulin present at the same time as the growth hormone signal. This is not speculative, it is the established mechanism, and it is why fasted states generally produce lower IGF-1 even when growth hormone levels are elevated. The liver is equipped to convert growth hormone into IGF-1, but the efficiency of that process is gated by insulin signaling in the hepatocytes, which are the liver cells doing the actual work. Growth hormone and insulin are working together here at the liver even though they work against each other everywhere else in the body.

That "everywhere else" part matters too, and it is where the timing problem starts.

Growth hormone is what is called counter-regulatory, which means it actively opposes insulin's effects in peripheral tissue like muscle and fat cells, and it does this specifically at the liver by reducing how sensitive that tissue is to insulin's glucose-lowering signal. A paper by Perriello and colleagues in 1990 showed this mechanism in detail, specifically that nocturnal growth hormone spikes are what produce the dawn phenomenon in type 1 diabetics, where fasting glucose rises overnight not because of anything the person ate but because growth hormone is suppressing hepatic insulin sensitivity in the early morning hours. The body's own nighttime pulse is responsible for that effect. An exogenous injection on top of it amplifies it.

Your body is already producing roughly 70 percent of its daily growth hormone output during the deep slow-wave portion of your sleep cycle, and this pulse typically peaks somewhere between midnight and 2 AM depending on when you fell asleep. A subcutaneous injection of growth hormone has a peak blood concentration around 4 hours post-injection based on pharmacokinetic data from Jorgensen and colleagues, which means a 10 PM injection is peaking right around 2 AM and sitting directly on top of the endogenous pulse your pituitary is already generating. Two overlapping peaks of a counter-regulatory hormone in the middle of the night, during a prolonged fast, with no insulin available for liver conversion. The glucose suppression effect compounds. The IGF-1 conversion opportunity is missed. You wake up with elevated fasting glucose and reduced insulin sensitivity, and the groggy heavy feeling that goes with it is your body telling you that the hormonal environment overnight was working against normal glucose regulation.

Now here is where the 1990 study gets misapplied. Jorgensen's evening versus morning comparison in GH-deficient patients found that 24-hour IGF-1 levels came out equivalent whether subjects injected in the evening or the morning. That result has been used to justify pre-bed timing ever since, but the subjects in that study had non-functioning pituitaries, meaning they had no endogenous pulse at all. There was no overnight peak to stack on top of. The counter-regulatory interference that occurs in someone with a working pituitary simply did not exist in that population. The study was not wrong. It was just answered a different question than the one most people using it are asking.

If your own pituitary is still producing its nightly pulse, the pre-bed injection is not neutral. It is additive in exactly the wrong direction.

Morning fasted timing works for the opposite set of reasons. When you pin first thing after waking, your growth hormone is climbing from baseline in a state where cortisol is already handling the normal morning glucose rise, and when you eat 30 to 60 minutes later, the insulin response from that first meal arrives while growth hormone is still ascending toward its 4-hour peak. That window is when the liver has both signals present simultaneously and can run the conversion efficiently. You are not missing insulin. You are not stacking on a free pulse. You are threading the injection into a moment where the biology is already pointing in the right direction.

At higher doses, specifically at 4 IU or above, a single morning injection may not sustain IGF-1 production across the full day, and the practical answer there is to split the dose with a second injection in the late afternoon, keeping the same principle intact. Late afternoon gives you another meal window where insulin will be present for conversion, and it is far enough from sleep that the 4-hour peak lands in the early evening rather than on top of the nocturnal pituitary pulse.

The simplest version of the protocol is this. Morning injection fasted, first meal 30 to 60 minutes later. If you are running 4 IU or more, split half to late afternoon before dinner. Do not pin at night unless your pituitary has actually stopped working, because if it has not, you have free growth hormone arriving every night and you do not need to add to it.

The deeper shift in understanding is this. Most people think of HGH timing as a question about absorption, and they assume the body processes exogenous hormone the same way regardless of when it arrives. But growth hormone does not exist in isolation. It operates inside a hormonal system that already has its own rhythm, its own pulse, and its own conversion requirements. The injection is entering that system, not replacing it, and where you place it in the daily cycle determines whether you are working with the system's existing structure or against it.

The pre-bed protocol was designed for people who had no system left to work with. That has never been the same problem.

---

References

1. Van Cauter E, Plat L. (1996). Physiology of growth hormone secretion during sleep. J Pediatr 128(5 Pt 2):S32-37. DOI: 10.1016/s0022-3476(96)70008-2
2. Jorgensen JO, Moller N, Moller J, Weeke J, Christiansen JS. (1985). Pharmacokinetics of biosynthetic authentic human growth hormone in normal men after subcutaneous or intramuscular injection. Acta Endocrinol (Copenh). PMID: 4034296
3. Jorgensen JO, Moller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. (1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 70(1):207-14. PMID: 2294131. DOI: 10.1210/jcem-70-1-207
4. Moller N, Jorgensen JO. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152-77. PMID: 19240267. DOI: 10.1210/er.2008-0027
5. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33(1):52-9. PMID: 2406181. DOI: 10.1007/BF00586461

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness